Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis - PubMed (original) (raw)

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis

C Buckley et al. Ann Neurol. 2001 Jul.

Abstract

Antibodies to muscle acetylcholine receptors, to other muscle antigens, and to some cytokines are found in the majority of patients with thymic tumors (thymomas) and myasthenia gravis (MG). The role of the tumor in initiating autoimmunity, however, is unclear; in particular, it is not known whether the thymoma exports mature and long-lived T cells, which could provide help for antibody production in the periphery. Here, we quantified recently exported thymic T cells using the approach of measuring episomal DNA fragments [T-cell receptor excision circles (TRECs)], generated by T-cell receptor gene rearrangement. Compared to values in healthy individuals (n = 10) or in patients with late-onset MG (n = 8), TREC levels were significantly raised in both the CD4+ and CD8+ peripheral blood compartments of patients with thymoma and MG (n = 14, p = 0.002 and p = 0.0004 compared to healthy controls) but only in the CD8+ compartment of the three patients with thymoma without MG (p = 0.4 and p = 0.01 for CD4+ and CD8+). TREC levels decreased following thymectomy to values similar to controls but were substantially raised in patients who had developed tumor recurrence (n = 6, p = 0.04 and p = 0.02 for CD4+ and CD8+); this was associated with increased antibodies to interferon-alpha and interleukin-12 in the one case studied serially. Collectively, these results support the hypothesis that the neoplastic thymoma tissue itself can generate and export mature, long-lived T cells and that these T cells reflect the thymic pathology and are likely to be related to the associated autoimmune diseases. The results also provide a new approach for early diagnosis of thymoma recurrence.

PubMed Disclaimer

Cited by

Myasthenia gravis: the future is here.
Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Kaminski HJ, et al. J Clin Invest. 2024 Jun 17;134(12):e179742. doi: 10.1172/JCI179742. J Clin Invest. 2024. PMID: 39105625 Free PMC article. Review.
Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Su XY, Wu WL, Liu N, Zhang SF, Li GD. Su XY, et al. Int J Clin Exp Pathol. 2014 Oct 15;7(11):7760-7. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25550813 Free PMC article.
Characterization of T cell maturity in thymic epithelial cell tumors from BUF/Mna spontaneous thymoma rats and BUF/Mna-Rnu/+ rats showing delayed thymomagenesis.
Inoue M, Matsuyama M, Shiono H, Honda O, Sumikawa H, Tomiyama N, Okumura M. Inoue M, et al. Int J Clin Exp Pathol. 2010 Jun 30;3(6):587-92. Int J Clin Exp Pathol. 2010. PMID: 20661406 Free PMC article.
Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience.
Nabe Y, Hashimoto T, Tanaka K, Fujita Y, Yoshimatsu K, Nemoto Y, Oyama R, Matsumiya H, Mori M, Kanayama M, Taira A, Shinohara S, Kuwata T, Takenaka M, Tashima Y, Kuroda K, Tanaka F. Nabe Y, et al. Gland Surg. 2021 Aug;10(8):2408-2413. doi: 10.21037/gs-21-287. Gland Surg. 2021. PMID: 34527552 Free PMC article.
Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis.
Altınönder İ, Kaya M, Yentür SP, Çakar A, Durmuş H, Yegen G, Özkan B, Parman Y, Sawalha AH, Saruhan-Direskeneli G. Altınönder İ, et al. J Neuroinflammation. 2024 May 11;21(1):126. doi: 10.1186/s12974-024-03095-7. J Neuroinflammation. 2024. PMID: 38734662 Free PMC article.

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis - PubMed (original) (raw)